European Medicines Agency

SNE/Scientific Specialist

European Medicines Agency  •  Kingdom of the Netherlands (Onsite)  •  5 hours ago
Apply
AI can make mistakes so check important info. Chat history is never stored.

Job Description

Type of position: Seconded National Expert
Reference: EMA/SNE/11507

Job title: SNE/Scientific Specialist
Deadline for applications: 25 June 2026 at 23.59 CET

The European Medicines Agency is a decentralized body of the European Union with all its offices and Headquarters based in Amsterdam, the Netherlands. Its core responsibility is the protection and promotion of public health through the evaluation and supervision of medicines.

We are looking for National experts on secondment. This means staff from other European public-sector bodies can work at the European Medicines Agency (EMA) for short periods of time through the national expert on secondment (SNE) programme. The aim of this programme is to enhance and develop the relationship between European public administrations.

SNEs serve a dual role: they bring their expertise to EMA and take back to their home administration the knowledge acquired during their period of secondment. SNEs remain in the service of their employer. Secondment is not equivalent to employment, nor does it lead to employment by EMA. Periods of secondment may last between six months and two years. This is renewable once or more, up to a total of four years.

This announcement is governed by the Rules governing the secondment of national experts. For further information please visit our Careers portal.

About this position:

The Agency is looking to strengthen the support it provides to clinical trials through the secondment of national experts for a period of one to two years (renewable). The Agency is working with the National Competent Authorities (NCAs) for medicines and the European Commission to optimise the EU clinical trials environment and this is being coordinated through Accelerating Clinical Trials in the EU (ACT EU) the EU transformation programme for clinical trials. EMA also operates and develops the Clinical Trials Information System (CTIS) and works with the NCAs and the Commission on the implementation of the Clinical Trials Regulation (CTR) including support to the Clinical Trials Coordination Group (CTCG).

Depending on the specific role, the position may involve:

  • strengthening support to the CTCG and to large multinational clinical trials, including initiatives such as FAST-EU and the pre-CTA consolidated advice process;
  • contributing to the further development and optimisation of CTIS, including in preparation for upcoming regulatory initiatives such as the Biotech Act;
  • supporting the design and implementation of activities under the ACT EU programme;
  • contributing to communication and change management activities related to ACT EU and CTIS; and
  • providing data analysis and insights to support EMA and the European Medicines Regulatory Network (EMRN).

In this role you will:

Working within the EMA Data Analytics and Methods Task Force you will be part of multidisciplinary teams at EMA and across the National Competent Authorities and European Commission. You will contribute to strengthening and transforming the European clinical trials environment, supporting key regulatory, scientific, and operational activities.

Depending on the specific position, you may:

  • support the day-to-day activities of the CTCG, including coordination and facilitation of collaborative procedures such as FAST-EU and the pre-CTA consolidated advice process to support multinational clinical trials;
  • contribute to the development and optimisation of CTIS, working with the clinical trials teams to define business requirements for new system functionalities introduced by the Biotech Act;
  • participate in the implementation of ACT EU initiatives, including cross-network projects and strategic actions aimed at improving the EU clinical trials landscape;
  • support communication, stakeholder engagement, and change management activities to promote effective use of CTIS, the upcoming implementation of the Biotech Act and broader ACT EU initiatives;
  • conduct data analysis to inform stakeholder needs and support decision-making across EMA and the EMRN.

Apply if you meet these eligibility criteria:

  1. Enjoy full rights as a citizen of an EU Member State, Iceland, Lichtenstein, Norway, Republic of Moldova or Ukraine;
  2. Have a thorough knowledge of English (at least level C1) and a satisfactory knowledge of another official language of the EU (at least level B2);
  3. Are currently employed in the public sector (such as a public intergovernmental organisation (IGO) national / regional /local public administration) in an EU Member State and are due to remain in such employment for the foreseen duration of the SNE position. ross EMA and the EMRN.

Essential requirements

Education

  • A level of education which corresponds to completed university studies of at least three years attested by a diploma;

Field of study
Life Science (e.g. biology, chemistry, biochemistry, pharmacy).
Experience

  • 3 years from the time when a university degree was awarded on completion of a minimum of three years of study;
  • Experience in either a competent authority in the field of medicines regulation, the pharmaceutical industry, national ethics body or in a healthcare / academic setting should have been obtained in:
    • The scientific, regulatory, or procedural aspects of the research, development, authorisation, productions or supervision of human or veterinary medicines
    • Working with medicinal products containing medical devices and associated regulatory framework.

Skills & Knowledge

  • Organisational skills
  • Communication skills
  • Critical review and drafting of scientific and regulatory documents for experts and lay audiences
  • Presenting scientific or regulatory matters at high level
  • Proficient in English language
  • Proficient in Ms office suite
  • Knowledge and understanding of The EU pharmaceutical legislation on the regulatory framework for pharmaceutical products in the EU.

These are considered as nice to have:

Education

  • Masters in a relevant field of study (Medicine or Life sciences);
  • Master’s degree in regulatory science and/or affairs.

Field of study

  • Scientific background relevant to perform the role.

Experience

  • In information analysis and reporting on scientific/regulatory matters;
  • Clinical experience in a therapeutic field;
  • Pharmaceutical development experience;
  • With medicines assessment at a National Competent Authority;
  • Regulatory scientists/product manager experience;
  • Knowledge of data collection and practices with data analysis tools;
  • Knowledge of training others in interpreting and using analytics;
  • In delivering, implementing and using data analytics solutions which include Artificial Intelligence components;
  • Experience in the preparation and/or review of any part of a clinical trial application dossier or scientific advice application;
  • Experience in working with stakeholders (industry and national/international authorities)

Timelines

Deadline for applications 24 June 2026 at 23:59 CET
Interviews From 01 July 2026
Decision expected 13 July 2026


Process
This post is published in line with Chapter II Art 4 of EMA/329753/2015 (European Medicines Agency Decision of 30 June 2015 laying down general implementing provisions on the procedure governing the engagement and use of temporary staff under Article 2(f) of the Conditions of Employment of Other Servants of the European Union).


The process will follow Annex I of Guidance on Internal Talent Marketplace.


Only eligible candidates (see eligibility criteria (i.e. temporary staff 2(f) who, on the closing date for applications and on the day of filling the post, are engaged within the agency in the function group and grade belonging to the grade bracket indicated in the internal publication.) will be assessed further.


The assessment of qualifications and suitability will be based solely on the required competencies, skills, knowledge, qualifications and experience for the role as stated in the internal publication.


Shortlisting
Talent Acquisition may publish additional pre-screening questions but, normally, the initial assessment will be conducted based on the application form submitted for an opening, and all eligible staff will be invited for a follow up assessment
Assessments
The assessments will include at the very least interviews and, only in specific circumstances, a written test, to identify the most suitable candidate.
In case of Head of Service roles, personality assessment or assessment of managerial competencies via assessment centre will be conducted.
Job offers
This publication is intended to fill a specific vacancy(ies), therefore, as a result of the assessments, the Selection Committee will recommend to the Executive Director the best candidate for the appointment, plus it may recommend 2-3 alternates from among those were found qualified and suitable for the specific vacancy in question. An additional interview with the hiring entity may be arranged before the final decision to recruit the candidate. Alternate candidates may be offered a position in case the initially selected candidate cannot take up the offer or their employment is not confirmed after probation period, but they are not placed in any reserve list. Alternate candidates may be appointed to other similar vacant post based on Art 7 of Staff Regulations.
The selected candidate, as well as all alternates, will be informed accordingly of the result of the internal publication.
Conditions of employment
The selected member of temporary staff 2(f) shall be assigned to the new post by written decision of the Executive Director without impact on his/her current contract of employment with the agency.

______________________________________________________________________________________________________
Domenico Scarlattilaan 6 - 1083 HS Amsterdam - The Netherlands
Telephone +31 (0)88 781 6000 - Email recruitment@ema.europa.eu

© European Medicines Agency, 2020. Reproduction is authorised provided the source is acknowledged.

European Medicines Agency

About European Medicines Agency

The European Medicines Agency (EMA) is a decentralised body of the European Union with headquarters in Amsterdam. Its main responsibility is the protection and promotion of public and animal health, through the evaluation and supervision of medicines for human and veterinary use.

Industry
Government & Public Safety
Company Size
1,001-5,000 employees
Headquarters
Amsterdam, NL
Year Founded
1995
Website
europa.eu
Social Media